Fotopoulou, Christina http://orcid.org/0000-0001-6375-9645
Berg, Thomas
Hausen, Annekristin
Hennig, René
Jalan, Rajiv
Malagó, Massimo
Capel, Jeroen
De Gottardi, Andrea
Stirnimann, Guido
Funding for this research was provided by:
Sequana Medical
Article History
Received: 25 July 2019
Accepted: 2 December 2019
First Online: 5 December 2019
Ethics approval and consent to participate
: This study was approved by the required institutional research committee of the participating centres. This study was approved by the following ethics committees: North West – Preston Research Ethics Committee (231306), Ethics Committee at the Medical Faculty of the University of Leipzig (346/17-ek), Rheinische Friedrich-Wilhelms-Universität Bonn Ethics Committee (280/17), State Medical Association Baden-Württemberg Ethics Committee (B-F-2017-118) and the Cantonal Ethics Committee of Bern (2017–01563). This study was undertaken in accordance with the principles of the Declaration of Helsinki of the World Medical Association.All living patients gave their written consent. For patients deceased at study inception, the requirement for informed consent was waived by each centre’s appropriate ethics committee.
: Consent for publication was waived by the ethics committee for deceased patients and consent was obtained for living individuals.
: All authors were compensated for the conduct of the study. Prof. Fotopoulou reports grants and personal fees from Sequana Medical to design study and write the paper, during the conduct of the study; advisory board of Roche, Ethicon, Tesaro, Pharmacokinesis, Olympus and Astra Zeneca, outside the submitted work. Prof. Berg reports grants and personal fees from Sequana Medical. Dr. Hausen reports speaker fees from Sequana Medical. Prof. Jalan received a grant from Thaurus, is a consultant for Takeda, board member for JHEP, a speaker for Grifols, outside the submitted work. Dr. Hennig, Prof. Malago and Prof. De Gottardi report no other conflicts of interest. Mr. Capel is an employee of Sequana Medical. Dr. Stirnimann reports being a consultant and speaker for Sequana Medical.